Published in Am J Clin Pathol on February 01, 2004
Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin Liver Dis (2008) 2.89
Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals. Nucleic Acids Res (2006) 1.98
Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis. Gastroenterology (2011) 1.52
Current concepts of mechanisms in drug-induced hepatotoxicity. Curr Med Chem (2009) 1.50
Apoptosis as a mechanism for liver disease progression. Semin Liver Dis (2010) 1.21
Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction. Crit Care (2009) 1.05
E2F-1 is overexpressed and pro-apoptotic in human hepatocellular carcinoma. Virchows Arch (2012) 0.89
Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis? World J Exp Med (2015) 0.85
Serum levels of keratin-18 fragments [tissue polypeptide-specific antigen (TPS)] are correlated with hepatocyte apoptosis in alcoholic hepatitis. Dig Dis Sci (2008) 0.82
Binding of TS1, an anti-keratin 8 antibody, in small-cell lung cancer after 177Lu-DOTA-Tyr3-octreotate treatment: a histological study in xenografted mice. EJNMMI Res (2011) 0.79
Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology (2008) 6.35
Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis. Nat Genet (2010) 4.69
Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol (2003) 2.69
Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation. Liver Transpl (2002) 2.18
Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C. Clin Infect Dis (2005) 1.83
Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes. Gastroenterology (2003) 1.79
The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. Am J Gastroenterol (2009) 1.70
Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment. Clin Infect Dis (2003) 1.65
Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. Hepatology (2006) 1.64
Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol (2004) 1.57
Influence of steroids on HCV recurrence after liver transplantation: A prospective study. J Hepatol (2007) 1.56
Thyroid autoimmunity in chronic idiopathic urticaria: implications for therapy. Am J Clin Dermatol (2002) 1.56
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. Transplantation (2006) 1.43
Thorough intraoperative analysis of breast sentinel lymph node biopsies: histologic and immunohistochemical findings. Surgery (2004) 1.42
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. Dig Dis Sci (2003) 1.37
Celiac disease in autoimmune cholestatic liver disorders. Am J Gastroenterol (2002) 1.23
Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness. J Hepatol (2006) 1.22
Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panel. Cancer (2002) 1.22
Expression of beta-galactoside alpha2,6 sialyltransferase and of alpha2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis. Glycobiology (2003) 1.13
A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology (2010) 1.10
Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up. Dig Dis Sci (2008) 1.08
454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples. Onco Targets Ther (2013) 1.08
Adipose-derived mesenchymal stem cells exert antiinflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients through prostaglandin E2. Arthritis Rheum (2013) 1.03
Treatment challenges and investigational opportunities in autoimmune hepatitis. Hepatology (2005) 1.02
Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer. Am J Clin Pathol (2008) 1.02
Increased expression of p16(INK4a) and p27(Kip1) cyclin-dependent kinase inhibitor genes in aging human kidney and chronic allograft nephropathy. Am J Kidney Dis (2003) 1.01
Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value. Clin Liver Dis (2008) 1.00
Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver. Liver Transpl (2002) 0.99
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. Liver Transpl (2004) 0.98
Susceptibility to thyroid disorders in hepatitis C. Clin Gastroenterol Hepatol (2005) 0.96
Primary diffuse meningeal melanomatosis: radiologic-pathologic correlation. AJNR Am J Neuroradiol (2003) 0.96
Slug gene expression supports human osteoblast maturation. Cell Mol Life Sci (2009) 0.96
Genetic distinctions between autoimmune hepatitis in Italy and North America. World J Gastroenterol (2005) 0.95
Adipose mesenchymal stem cells protect chondrocytes from degeneration associated with osteoarthritis. Stem Cell Res (2013) 0.95
Predictive value of biological markers for hepatocellular carcinoma patients treated with orthotopic liver transplantation. Clin Cancer Res (2004) 0.95
Hepatocyte proliferation and apoptosis in relation to oxidative damage in alcohol-related liver disease. Alcohol Alcohol (2002) 0.94
Assessment of a chemically induced model of lung squamous cell carcinoma in mice by 18F-FDG small-animal PET. Nucl Med Commun (2007) 0.94
Intrahepatic hepatitis C virus RNA quantification in microdissected hepatocytes. J Hepatol (2004) 0.93
PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis. Am J Gastroenterol (2009) 0.93
Smooth muscle antibodies and type 1 autoimmune hepatitis. Autoimmunity (2002) 0.91
Role of Slug transcription factor in human mesenchymal stem cells. J Cell Mol Med (2012) 0.88
Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study. Liver Transpl (2006) 0.87
T cell suppression by osteoclasts in vitro. J Cell Physiol (2011) 0.86
Primary paraganglioma strictly confined to the liver and mimicking hepatocellular carcinoma: an immunohistochemical and in situ hybridization study. Am J Surg Pathol (2002) 0.86
Autoimmune hepatitis in Italy: the Bologna experience. J Hepatol (2009) 0.85
Natural course of chronic HCV and HBV infection and role of alcohol in the general population: the Dionysos Study. Am J Gastroenterol (2008) 0.84
A multiorgan donor cancer screening protocol: the Italian Emilia-Romagna region experience. Transplantation (2003) 0.84
Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule. J Immunol (2002) 0.84
Parvovirus b19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease. J Clin Microbiol (2009) 0.83
Real time RT-PCR approach for the evaluation of ERBB2 overexpression in breast cancer archival samples: a comparative study with FISH, SISH, and immunohistochemistry. Diagn Mol Pathol (2008) 0.83
Autoimmune liver disease 2007. Mol Aspects Med (2007) 0.83
Systemic lupus erythematosus following virological response to peginterferon alfa-2b in a transplanted patient with chronic hepatitis C recurrence. World J Gastroenterol (2006) 0.83
Enhanced monocyte Th1 cytokine production in HCV-infected cryoglobulinemic patients. J Hepatol (2003) 0.82
The hepatitic/cholestatic "overlap" syndrome: an Italian experience. Autoimmunity (2002) 0.81
Antitransglutaminase antibodies and giardiasis. Am J Gastroenterol (2004) 0.81
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. Liver Transpl (2007) 0.81
Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. Liver Int (2004) 0.81
Immunoglobulin GM and KM allotypes and prevalence of anti-LKM1 autoantibodies in patients with hepatitis C virus infection. J Virol (2006) 0.81
Detection of HCV antigens in liver graft: relevance to the management of recurrent post-liver transplant hepatitis C. Liver Transpl (2006) 0.81
Ragweed pollen travels long distance. Ann Allergy Asthma Immunol (2006) 0.80
Etanercept and infliximab induce the same serological autoimmune modifications in patients with rheumatoid arthritis. Rheumatol Int (2007) 0.80
Application of the 2010 American Association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis. Hepatology (2010) 0.80
Acute icteric hepatitis induced by a short course of low-dose cyclophosphamide in a patient with lupus nephritis. Dig Dis Sci (2005) 0.80
Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation. Liver Transpl (2008) 0.80
Autoantibody appearance in cytomegalovirus-infected liver transplant recipients: correlation with antigenemia. J Med Virol (2002) 0.79
Quantification of free plasma DNA before and after chemotherapy in patients with advanced epithelial ovarian cancer. Diagn Mol Pathol (2008) 0.78
Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C. J Hepatol (2009) 0.78
A case of leptospirosis simulating colon cancer with liver metastases. World J Gastroenterol (2004) 0.78
Evidence of specific characteristics and osteogenic potentiality in bone cells from tibia. J Cell Physiol (2011) 0.78
Hepatitis C and autoreactivity. Dig Liver Dis (2007) 0.78
Orthotopic liver transplantation (OLT): Contribution of imaging and interventional radiology in preparing the transplantation and managing complications. Part 2: Post-OLT complications and their treatment. Radiol Med (2006) 0.78
Laboratory test variability and model for end-stage liver disease score calculation: effect on liver allocation and proposal for adjustment. Transplantation (2007) 0.78
Slug contributes to the regulation of CXCL12 expression in human osteoblasts. Exp Cell Res (2010) 0.78
Metabolic, coagulative, and hemodynamic changes during intestinal transplant: good predictors of postoperative damage? Transplantation (2007) 0.77
Detection of recipient's cells in liver graft using antibodies to mismatched HLA class I antigens. Liver Transpl (2004) 0.77
Changes in atopy over 25 years: atopy now affects wider age range. BMJ (2005) 0.77
Multiple nuclear dots and rim-like/membranous IgG isotypes in primary biliary cirrhosis. Autoimmunity (2009) 0.77
Transcription factor decoy against NFATc1 in human primary osteoblasts. Int J Mol Med (2011) 0.77
Allergy to fungal allergens in northern Italy. Ann Allergy Asthma Immunol (2004) 0.77
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation. World J Gastroenterol (2013) 0.77